ARCHIVES

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Control Needs More Oncologists, DCT recruiting for Prestigious Combines Job

November 21, 1975

Drug Slows Tumor Growth In Metastatic Kidney Cancer

July 26, 2002

In Congress: Could NCI Make Use Of Increase? Porter Asks; “We Can Handle It Well,” Klausner Replies

April 3, 1998

Study Finds Trial Results Reliable At Three Years

July 29, 2005

CIS Recompetition Approved, But BSC Delays Decision On Matching Requirement

May 15, 1987

IG Report Clears Shubik Of Conflict Of Interest Change

October 6, 1978